Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-30428575

RESUMEN

Household air pollution is estimated to be responsible for nearly three million premature deaths annually. Measuring fractional exhaled nitric oxide (FeNO) may improve the limited understanding of the association of household air pollution and airway inflammation. We evaluated the cross-sectional association of FeNO with exposure to household air pollution (24-h average kitchen and personal fine particulate matter and black carbon; stove type) among 139 women in rural Honduras using traditional stoves or cleaner-burning Justa stoves. We additionally evaluated interaction by age. Results were generally consistent with a null association; we did not observe a consistent pattern for interaction by age. Evidence from ambient and household air pollution regarding FeNO is inconsistent, and may be attributable to differing study populations, exposures, and FeNO measurement procedures (e.g., the flow rate used to measure FeNO).


Asunto(s)
Contaminación del Aire Interior/efectos adversos , Inflamación/etiología , Exposición por Inhalación/efectos adversos , Óxido Nítrico/análisis , Humo/efectos adversos , Adulto , Contaminación del Aire , Contaminación del Aire Interior/análisis , Biomasa , Pruebas Respiratorias , Culinaria , Estudios Transversales , Espiración , Composición Familiar , Femenino , Honduras , Artículos Domésticos , Humanos , Exposición por Inhalación/análisis , Persona de Mediana Edad , Material Particulado/análisis , Población Rural , Humo/análisis
2.
Crit Care Med ; 44(10): 1861-70, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27359085

RESUMEN

OBJECTIVES: The 2009-2010 influenza A (H1N1pdm09) pandemic caused substantial morbidity and mortality among young patients; however, mortality estimates have been confounded by regional differences in eligibility criteria and inclusion of selected populations. In 2013-2014, H1N1pdm09 became North America's dominant seasonal influenza strain. Our objective was to compare the baseline characteristics, resources, and treatments with outcomes among critically ill patients with influenza A (H1N1pdm09) in Mexican and Canadian hospitals in 2014 using consistent eligibility criteria. DESIGN: Observational study and a survey of available healthcare setting resources. SETTING: Twenty-one hospitals, 13 in Mexico and eight in Canada. PATIENTS: Critically ill patients with confirmed H1N1pdm09 during 2013-2014 influenza season. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The main outcome measures were 90-day mortality and independent predictors of mortality. Among 165 adult patients with H1N1pdm09-related critical illness between September 2013 and March 2014, mean age was 48.3 years, 64% were males, and nearly all influenza was community acquired. Patients were severely hypoxic (median PaO2-to-FIO2 ratio, 83 mm Hg), 97% received mechanical ventilation, with mean positive end-expiratory pressure of 14 cm H2O at the onset of critical illness and 26.7% received rescue oxygenation therapy with prone ventilation, extracorporeal life support, high-frequency oscillatory ventilation, or inhaled nitric oxide. At 90 days, mortality was 34.6% (13.9% in Canada vs 50.5% in Mexico, p < 0.0001). Independent predictors of mortality included lower presenting PaO2-to-FIO2 ratio (odds ratio, 0.89 per 10-point increase [95% CI, 0.80-0.99]), age (odds ratio, 1.49 per 10 yr increment [95% CI, 1.10-2.02]), and requiring critical care in Mexico (odds ratio, 7.76 [95% CI, 2.02-27.35]). ICUs in Canada generally had more beds, ventilators, healthcare personnel, and rescue oxygenation therapies. CONCLUSIONS: Influenza A (H1N1pdm09)-related critical illness still predominantly affects relatively young to middle-aged patients and is associated with severe hypoxemic respiratory failure. The local critical care system and available resources may be influential determinants of patient outcome.


Asunto(s)
Enfermedad Crítica/terapia , Subtipo H1N1 del Virus de la Influenza A , Gripe Humana/fisiopatología , Gripe Humana/terapia , Unidades de Cuidados Intensivos/estadística & datos numéricos , Corticoesteroides/economía , Corticoesteroides/uso terapéutico , Adulto , Anciano , Antivirales/economía , Antivirales/uso terapéutico , Canadá/epidemiología , Enfermedad Crítica/epidemiología , Oxigenación por Membrana Extracorpórea/economía , Oxigenación por Membrana Extracorpórea/métodos , Femenino , Gastos en Salud , Humanos , Gripe Humana/economía , Gripe Humana/epidemiología , Masculino , México/epidemiología , Persona de Mediana Edad , Respiración Artificial/economía , Respiración Artificial/métodos , Insuficiencia Respiratoria/fisiopatología , Insuficiencia Respiratoria/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA